Related content

Receptors in neurodegenerative diseases, muscarinic cholinergic receptors

By Angeli P.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite

Receptors in neurodegenerative diseases

By Froestl W.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 247-251

Elsevier

Access to resources Recommend Favorite

Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1294-1303

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 11, Iss. 1, 2012-06 ,pp. : 20-36

Bentham Science Publishers

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite